Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Stopped Terminated for the safety of cystic fibrosis clinical trial subjects due to Covid-19.
Conditions
Interventions
- DRUG: Nitric Oxide 160 ppm
Sponsor
Novoteris, LLC
Collaborators
- [object Object]
- [object Object]